| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1970775 | Clinical Biochemistry | 2006 | 8 Pages |
Abstract
The Elecsys® S100 system appears to be suitable for rapid real-time detection of neurological deficits in patients undergoing CAS and CEA. Persistent elevations of Elecsys® S100 levels during CEA were associated with prolonged neurological disorders, whereas transient increases seem to represent impaired blood-brain barrier integrity without neurological deficits.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Thomas Mussack, Volker Klauss, Volker Ruppert, Cornelia Gippner-Steppert, Peter Biberthaler, Uwe Schiemann, Ulrich Hoffmann, Marianne Jochum,